Validity Evidence for the LittlEARS Early Speech Production Questionnaire: An English-Speaking, Canadian Sample.


Journal

Journal of speech, language, and hearing research : JSLHR
ISSN: 1558-9102
Titre abrégé: J Speech Lang Hear Res
Pays: United States
ID NLM: 9705610

Informations de publication

Date de publication:
25 10 2019
Historique:
pubmed: 17 9 2019
medline: 2 10 2020
entrez: 17 9 2019
Statut: ppublish

Résumé

Purpose This study reports validity evidence for an English translation of the LittlEARS Early Speech Production Questionnaire (LEESPQ). The LEESPQ was designed to support early spoken language outcome monitoring in young children who are deaf/hard of hearing. Methods Data from 90 children with normal hearing, ages 0-18 months, are reported. Parents completed the LEESPQ in addition to a concurrent measure of spoken language development, the Receptive-Expressive Emergent Language Test-Third Edition. Normal hearing status and development were confirmed. Results Traditional scale analyses, in addition to item parameters, are reported. The LEESPQ was highly correlated with the Receptive-Expressive Emergent Language Test-Third Edition (

Identifiants

pubmed: 31525125
doi: 10.1044/2019_JSLHR-L-18-0411
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3667-3678

Auteurs

Olivia Daub (O)

Graduate Program in Health and Rehabilitation Sciences, The University of Western Ontario, London, Canada.

Janis Oram Cardy (JO)

School of Communication Sciences and Disorders, The University of Western Ontario, London, Canada.

Andrew M Johnson (AM)

School of Health Studies, The University of Western Ontario, London, Canada.

Marlene P Bagatto (MP)

School of Communication Sciences and Disorders, The University of Western Ontario, London, Canada.
National Centre for Audiology, The University of Western Ontario, London, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH